Since SLC2A3 or GLUT3 genes are associated with prognosis in CRC as well as thyroid or laryngeal carcinoma, it would be worthwhile to investigate whether these cancers have similar GLUT-dependent metabolic pathways. This evidence concerns the gene SLC2A3 and colorectal carcinoma.